We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STCN
5201
DELISTED
Steel Connect, Inc. Common Stock
STCN
$5K ﹤0.01%
+414
New +$5.24K
APTO
5202
DELISTED
Aptose Biosciences, Inc.
APTO
$5K ﹤0.01%
20
+4
+25% +$1.38K
ACOR
5203
DELISTED
Acorda Therapeutics
ACOR
$5K ﹤0.01%
761
-601
-44% -$5.03K
CDAK
5204
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$5K ﹤0.01%
6,573
+3,780
+135% +$7.93K
OBSV
5205
DELISTED
ObsEva SA Ordinary Shares
OBSV
$5K ﹤0.01%
35,191
+17,734
+102% +$10.7K
BGSX.U
5206
DELISTED
Build Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
BGSX.U
$5K ﹤0.01%
462
FPAC
5207
DELISTED
Far Peak Acquisition Corporation
FPAC
$5K ﹤0.01%
508
+291
+134% +$2.87K
FTEV.U
5208
DELISTED
FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant
FTEV.U
$5K ﹤0.01%
482
LGAC
5209
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$5K ﹤0.01%
500
+66
+15% +$652
ATNX
5210
DELISTED
Athenex, Inc. Common Stock
ATNX
$5K ﹤0.01%
942
+67
+8% +$689
FFBW
5211
DELISTED
FFBW, Inc. Common Stock
FFBW
$5K ﹤0.01%
412
-151
-27% -$1.84K
MIT
5212
DELISTED
Mason Industrial Technology, Inc.
MIT
$5K ﹤0.01%
468
-40
-8% -$391
PRBM
5213
DELISTED
Parabellum Acquisition Corp.
PRBM
$5K ﹤0.01%
520
-3
-0.6% -$30
BIOR
5214
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$5K ﹤0.01%
42
+5
+14% +$900
SPGS
5215
DELISTED
Simon Property Group Acquisition Holdings, Inc.
SPGS
$5K ﹤0.01%
537
-115
-18% -$1.13K
GROM
5216
DELISTED
Grom Social Enterprises Inc. Common Stock
GROM
$5K ﹤0.01%
27
+4
+17% +$952
NDACU
5217
DELISTED
NightDragon Acquisition Corp. SCALE Units
NDACU
$5K ﹤0.01%
477
EMWP
5218
DELISTED
Eros Media World PLC
EMWP
$5K ﹤0.01%
+10,389
New +$20.9K
MTRYU
5219
DELISTED
Monterey Innovation Acquisition Corp. Unit
MTRYU
$5K ﹤0.01%
445
-5
-1% -$51
AGNG icon
5220
Global X Aging Population ETF
AGNG
$89.8M
$4K ﹤0.01%
+181
New +$4.59K
ALV icon
5221
Autoliv
ALV
$8.89B
$4K ﹤0.01%
62
-3,007
-98% -$233K
ARMP icon
5222
Armata Pharmaceuticals
ARMP
$177M
$4K ﹤0.01%
904
-209
-19% -$841
ARTL icon
5223
Artelo Biosciences
ARTL
$2.64M
$4K ﹤0.01%
70
+52
+289% +$4.19K
AUID icon
5224
authID Inc
AUID
$7.91M
$4K ﹤0.01%
+145
New +$3.35K
BKN
5225
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
$4K ﹤0.01%
+358
New +$5.22K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.